The Dermatology Digest

DECEMBER 3, 2024

The Medicines and Healthcare Products Regulatory Agency (MHRA) has granted marketing authorization in Great Britain for delgocitinib cream (Anzupgo, Leo Pharma) for the treatment of adult patients with moderate to severe chronic hand eczema (CHE), for whom topical corticosteroids are inadequate or inappropriate.

Marketing 36

Marketing Eczema Safety Management 36

Les Nouvelles Esthetics & Spa

FEBRUARY 29, 2024

Inclusivity and client safety are key in the design of these systems. Ensuring that practices are accessible to all clients, regardless of background, and that safety protocols are rigorously maintained, is essential. By prioritizing client experience and operational efficiency, practices can distinguish themselves in a crowded market.

Innovations 78

Innovations Management Client Safety Client Care 78

The Dermatology Digest

APRIL 16, 2024

Market Access at Teva, in a news release. Bringing Selarsdi to market in the U.S. “The approval of Selarsdi – which is our second biosimilar approval this year – underscores Teva’s commitment to expanding the availability, access and uptake of this important treatment option to patients in the U.S.,”

Partnerships 74

Partnerships Injections Safety Marketing 74

Aesthetics Exposed

DECEMBER 30, 2017

Peels are one of the most useful tools in a skin care professional's arsenal, but they must be used correctly to ensure not only efficacy but also safety. Listed here are five ways to modify a peel to safely increase skin care efficacy. Salicylic acid is a beta hydroxy acid (BHA) that is lipid-soluble, meaning it is attracted to oil.

Chemical Peels 195

Chemical Peels Exfoliation Dermaplaning Sensitive Skin 195

The Dermatology Digest

NOVEMBER 14, 2024

Regulatory filings in other markets are underway. In addition, the Swiss approval is supported by the results from the head-to-head DELTA FORCE Phase 3 clinical trial, which evaluated the efficacy and safety of delgocitinib cream compared with oral alitretinoin capsules. The cream is fast-tracked by the U.S. .”

Marketing 36

Marketing Eczema Safety Innovations 36

Online Laser Training

DECEMBER 8, 2019

Dr Godfrey Town gave a talk on ‘ Update on Home-Use Devices: New Devices, Regulations & Safety ’ as an Invited Speaker at the new European Congress on Advanced Treatments and Technologies in Skin & Aesthetics (Skin-Med2019) annual conference held 5th to 8th December 2019 at the Holton Munich City Hotel in Germany.

Technology 60

Technology Treatments Safety Medical 60

Online Laser Training

DECEMBER 8, 2019

Dr Godfrey Town gave a talk on ‘ Update on Home-Use Devices: New Devices, Regulations & Safety ’ as an Invited Speaker at the new European Congress on Advanced Treatments and Technologies in Skin & Aesthetics (Skin-Med2019) annual conference held 5th to 8th December 2019 at the Holton Munich City Hotel in Germany.

Technology 60

Technology Treatments Safety Medical 60

The Dermatology Digest

DECEMBER 18, 2024

The clinical results demonstrated that STEQEYMA and its reference product, ustekinumab, are highly similar, and have no clinically meaningful differences in terms of safety and efficacy. immunology market.” “STEQEYMA is now the latest biologic in our immunology portfolio, joining ZYMFENTRA (infliximab-dyyb). .

Portfolios 68

Portfolios Injections Office Safety 68

The Dermatology Digest

FEBRUARY 14, 2024

In addition, the European Medicines Agency has also accepted the Marketing Authorization Applications for nemolizumab in prurigo nodularis and atopic dermatitis. The European Medicines Agency has also accepted Galderma’s Marketing Authorization Applications for nemolizumab in both prurigo nodularis and atopic dermatitis.

Dermatitis 78

Dermatitis Clinic Safety Dermatology 78

The Dermatology Digest

APRIL 23, 2024

The CRL did not identify any deficiencies related to the clinical efficacy or clinical safety data in the BLA, and the FDA did not request any new clinical trials or clinical data to support the approval of pz-cel. The BLA for pz-cel was accepted for filing and granted priority review designation by the FDA in November 2023.

Marketing 36

Marketing Safety Clinic Sustainability 36

The Beauty Brains

MAY 13, 2019

The Beauty Brains episode 182 – we cover beauty questions about BB glow facials The safety of self tanners Doing you own research and Hard water and your beauty products Beauty Science News Butt Masks Is natural deodorant necessary ? So, with the uncertain safety profile and the limited benefit I’m not sure I can recommend doing this.

Safety 40

Safety Facials Injections Ingredients 40

The Dermatology Digest

NOVEMBER 4, 2024

The EU Medical Device Regulation (MDR) certification gave its nod to four injectable hyaluronic acid (HA) gel fillers from Evolus under the brand name Estyme, The CE Mark certification, through the new MDR process, represents more stringent requirements, designed to ensure the safety, efficacy, and quality of medical devices sold in Europe.

Injections 68

Injections Medical Portfolios Branding 68

AAAMS

NOVEMBER 13, 2024

Adding cosmetic injections to your dental practice offers several benefits, from enhancing patient satisfaction to differentiating your services in a competitive market. By expanding into this area, dental professionals can tap into a growing market of patients seeking non-invasive cosmetic enhancements.

Injections 52

Injections Training Facials Surgery 52

The Dermatology Digest

FEBRUARY 26, 2024

Swierk noted that the research on the safety implications of tattoos is still out. Regulation of tattoo inks on the American market is very recent. The tattoo inks available in the American and European markets differ because the latter is subject to stricter regulations, overseen by the European Chemicals Agency.

Ingredients 74

Ingredients Marketing Safety Dermatology 74

AAAMS

DECEMBER 19, 2024

Understanding patient safety protocols and treatment planning. Build and Market Your Practice Once youre trained and certified, its time to start building your practice. Leverage marketing tools like a professional website, active social media presence, and patient reviews. How do I attract patients to my practice?

Social Media 52

Social Media Work-Life Balance Training Microneedling 52

The Eco Well Blog

JUNE 14, 2024

Or are they putting these guides out as a fear marketing campaign to promote the EWG seal program (which makes them money)? But hopefully it gives you the gist of why it’s unreliable and why I’ve come to the conclusion that these guides are part of a greater marketing campaign by the EWG. market while tests are still being conducted.

Sun Protection 52

Sun Protection Safety Ingredients Marketing 52

AAAMS

DECEMBER 16, 2024

AAAMS offers comprehensive courses that teach you the latest techniques while focusing on patient safety and satisfaction. Certification also ensures you meet industry standards for safety and effectiveness. Invest in marketing strategies like social media, before-and-after photos, and patient testimonials to showcase your expertise.

Chemical Peels 52

Chemical Peels Microneedling Social Media Surgery 52

Cosmetify

JULY 3, 2023

Key Steps in Personal Care Manufacturing: Research and Development: This is the initial phase where manufacturers study market trends and consumer preferences and conduct research to formulate innovative and effective products. These challenges require strategic planning, efficient operations, and adaptability to changing market dynamics.

Marketing 52

Marketing Innovations Ethics Branding 52

NIMA Institute

JUNE 30, 2023

Safety and Ethical Practices: Nima places a strong emphasis on safety and ethical practices in Botox and filler administration. Nima’s commitment to safety ensures that you are equipped with the knowledge and skills to prioritize the well-being of your patients and deliver optimal outcomes.

Training 52

Training Medical Esthetics Ethics Esthetics 52

The Dermatology Digest

FEBRUARY 26, 2024

Marketing Authorization Application. About the MIRA trial The MIRA trial (M1095-HS-201) is a global, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of the Nanobody sonelokimab, administered subcutaneously, in the treatment of adult patients with active moderate-to-severe hidradenitis suppurativa.

Office 74

Office Clinic Safety Innovations 74

The Dermatology Digest

MARCH 22, 2024

1,2 Benzene has become a more recent focus of attention related to safety concerns, with an increase in independent product testing and also updated regulations by the Food and Drug Administration related to benzene. Public safety is the first priority of the AARS. Right now, there are many questions about this issue.

Rosacea 64

Rosacea Document Safety Ingredients 64

Maxine Drake

OCTOBER 27, 2023

Impeccable Hygiene and Safety Hygiene and safety are non-negotiable in our industry. This commitment to safety will foster trust and confidence among your clients. Competitive Edge In a crowded market, having “super” procedures can be your competitive advantage.

Esthetics 52

Esthetics Customer Service Safety Consultations 52

AAAMS

DECEMBER 19, 2024

This foundational knowledge is critical for practitioners who wish to perform aesthetic procedures with precision, confidence, and a commitment to patient safety. Our facial aesthetics program provides a detailed understanding of facial anatomy, physiognomy, and essential techniques, such as Botox and dermal filler injections.

Medical 52

Medical Networking Ethics Surgery 52

Cosmetify

AUGUST 2, 2023

Whether you’re an entrepreneur, a small business, or an established brand, our private label services enable you to market high-quality cosmetics under your brand name. With a wide range of products, we ensure that your private-label products meet industry standards and captivate your target market.

Ethics 52

Ethics Innovations Branding Ingredients 52

Cosmetify

JANUARY 15, 2024

Market Research: Begin your journey by delving into thorough market research. Understand the existing landscape, identify gaps in the market, and pinpoint your unique value proposition. Sampling and testing ensure that your products meet the highest standards of safety and effectiveness.

Extractions 52

Extractions Branding Irritation Moisturization 52

The Dermatology Digest

FEBRUARY 27, 2024

While both low-concentration and high-concentration strength biosimilars of Humira are marketed in the U.S. We strongly believe that biosimilars are important in addressing inflationary pressures in the healthcare system across all markets, especially in the U.S. Both Alvotech and Teva expect to launch SIMLANDI in the U.S.

Safety 36

Safety Marketing Pharmaceutical Partnerships 36

The Dermatology Digest

FEBRUARY 8, 2024

Jashin Wu, MD, founder and CEO of the Dermatology Research and Education Foundation in San Diego, CA, says that more psoriasis patients will see improvements in their condition due to the influx of new agents and biosimilars on the market. It has great efficacy and safety and is oral… [This means] no shot and no risk of anaphylaxis.”

Dermatology 78

Dermatology Eczema Pharmaceutical Dermatitis 78

The Dermatology Digest

FEBRUARY 16, 2024

The Ministry of Health, Labor and Welfare (MHLW) in Japan has granted marketing and manufacturing authorization for dupilumab (Dupixent, Sanofi and Regeneron Pharmaceuticals, Inc.) The safety profile of dupilumab in CSU was generally consistent with the known safety of Dupixent in its approved dermatological indications.

Pharmaceutical 36

Pharmaceutical Safety Dermatitis Therapy 36

Cosmetify

JULY 30, 2023

Some of these benefits are: Expertise and resources: Third-party manufacturers are experts who have state-of-the-art facilities, experienced, qualified, and knowledgeable staff, and technical and market expertise to carry out production with ease. This includes adhering to product safety, labeling, and packaging regulations.

Cosmetic Products 52

Cosmetic Products Branding Legal Partnerships 52

The Dermatology Digest

NOVEMBER 30, 2024

Several new therapies are coming down the pike for the treatment of lichen planus, a chronic inflammatory condition that affects an estimated 1% to 2% of the global population, according to a new report from Research and Markets. Incyte is investigating the efficacy and safety of ruxolitinib cream in cutaneous lichen planus.

Pharmaceutical 36

Pharmaceutical Safety Marketing Therapy 36

Style Seat - Business Growth

JULY 23, 2024

Consider your target market as well. Understanding your target audience will help you tailor your services, pricing, and marketing strategies to attract and retain clients. Develop a comprehensive business plan With your spa concept and target market in mind, it’s time to create a detailed business plan.

Customer Service 40

Customer Service Legal Sanitation Marketing 40

The Dermatology Digest

JUNE 14, 2024

Currently, no TYK2 inhibitors have obtained marketing approval for the treatment of AD. ICP-332 achieved multiple efficacy endpoints in the China Phase II study of patients with moderate-to-severe AD and demonstrated an “outstanding” and safety profile.

Dermatitis 36

Dermatitis Marketing Safety Innovations 36

The Dermatology Digest

DECEMBER 4, 2024

Restem’s ULSC therapy has shown promising results in early clinical trials, demonstrating safety, tolerability and initial clinically significant improvements, as well as the potential to significantly reduce the need for steroid use in patients. The company is currently preparing for Phase 2/3 trials with anticipated initiation in 1Q 2025.

Treatments 36

Treatments Office Therapy Clinic 36

The Dermatology Digest

SEPTEMBER 30, 2024

market, is an important milestone on our pathway to consistently broadening our biopharma portfolio in the U.S. Otulfi demonstrated comparable efficacy, safety, pharmacokinetics and immunogenicity to Stelara in patients with moderate to severe psoriasis vulgaris. This marks the fourth FDA-approved biosimilar for Stelara.

Portfolios 36

Portfolios Partnerships Marketing Safety 36

The Dermatology Digest

JULY 22, 2024

Launching Uzpruvo at the earliest opportunity in Europe’s largest pharmaceutical markets, promotes access by creating competition,” says STADA CEO Peter Goldschmidt in a news release. We are delighted at the launch of Uzpruvo in Europe and to be first-to-market,” adds Robert Wessman, Chief Executive Officer of Alvotech.

Partnerships 36

Partnerships Pharmaceutical Marketing Office 36

Lori Crete

MAY 15, 2023

” – Lori Crete Lori’s 4 Outside-the-Biz Elements to Know: Numbers Website Social Media Marketing “Clients will find you and book with you online if they feel drawn to your unique brand.”

Social Media 40

Social Media Marketing Safety Management 40

Spa Executive

JULY 17, 2024

Offering a full spectrum of services, from design and brand development to recruiting, marketing, and day-to-day operations, Arch Amenities Group transforms key areas into activated, profitable spaces.

Technology 98

Technology Hospital Sustainability Innovations 98